Cited by 748HIV/AIDS Research and InterventionsHIV-related health complications and treatmentsHIV, Drug Use, Sexual Risk

The DOI matches its Crossref record; 21 of the 21 references it cites were found in a registry or an index.

. Survival of persons with and without HIV infection in Denmark, 1995-2005.

Lohse, Nicolai, Hansen, Ann-Brit Eg, Pedersen, Gitte, Kronborg, Gitte, Gerstoft, Jan, Sørensen, Henrik Toft, Væth, Michael, Obel, Niels·2007·Annals of Internal Medicine

DOI 10.7326/0003-4819-146-2-200701160-00003

Open this paper in CoChat — free account

Abstract

BACKGROUND: The expected survival of HIV-infected patients is of major public health interest. OBJECTIVE: To estimate survival time and age-specific mortality rates of an HIV-infected population compared with that of the general population. DESIGN: Population-based cohort study. SETTING: All HIV-infected persons receiving care in Denmark from 1995 to 2005. PATIENTS: Each member of the nationwide Danish HIV Cohort Study was matched with as many as 99 persons from the general population according to sex, date of birth, and municipality of residence. MEASUREMENTS: The authors computed Kaplan-Meier life tables with age as the time scale to estimate survival from age 25 years. Patients with HIV infection and corresponding persons from the general population were observed from the date of the patient's HIV diagnosis until death, emigration, or 1 May 2005. RESULTS: 3990 HIV-infected patients and 379,872 persons from the general population were included in the study, yielding 22,744 (median, 5.8 y/person) and 2,689,287 (median, 8.4 years/person) person-years of observation. Three percent of participants were lost to follow-up. From age 25 years, the median survival was 19.9 years (95% CI, 18.5 to 21.3) among patients with HIV infection and 51.1 years (CI, 50.9 to 51.5) among the general population. For HIV-infected patients, survival increased to 32.5 years (CI, 29.4 to 34.7) during the 2000 to 2005 period. In the subgroup that excluded persons with known hepatitis C coinfection (16%), median survival was 38.9 years (CI, 35.4 to 40.1) during this same period. The relative mortality rates for patients with HIV infection compared with those for the general population decreased with increasing age, whereas the excess mortality rate increased with increasing age. LIMITATIONS: The observed mortality rates are assumed to apply beyond the current maximum observation time of 10 years. CONCLUSIONS: The estimated median survival is more than 35 years for a young person diagnosed with HIV infection in the late highly active antiretroviral therapy era. However, an ongoing effort is still needed to further reduce mortality rates for these persons compared with the general population.

Integrity signals

Registry

Crossref · 10.7326/0003-4819-146-2-200701160-00003

Cites

21 of 21 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Decline in the AIDS and death rates in the EuroSIDA study: an observational study
Mocroft, A., Ledergerber, B., Katlama, C., Kirk, O., Reiss, P., Monforte, A. D., Knysz, B., Dietrich, M., Phillips, A. N., & Lundgren, J. D. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13802-0 · Cited by 1,241
When an Entire Country Is a Cohort
Frank, L. (2000) · Science · doi:10.1126/science.287.5462.2398 · Cited by 865
The prevalence of alcohol consumption and heavy drinking among people with HIV in the United States: results from the HIV Cost and Services Utilization Study.
Galván, F. H., Bing, E. G., Fleishman, J. A., London, A. S., Caetano, R., Burnam, M. A., Longshore, D. L., Morton, S. C., Orlando, M., & Shapiro, M. F. (2002) · Journal of Studies on Alcohol · doi:10.15288/jsa.2002.63.179 · Cited by 438
The British Diabetic Association Cohort Study, I: all‐cause mortality in patients with insulin‐treated diabetes mellitus
Laing, S. P., Swerdlow, A. J., Slater, S. D., Botha, J. L., Burden, A. C., Waugh, N. R., Smith, A. W. M., Hill, R. D., Bingley, P. J., Patterson, C. C., et al. (1999) · Diabetic Medicine · doi:10.1046/j.1464-5491.1999.00075.x · Cited by 427
Risk Factors for Coronary Heart Disease in Patients Treated for Human Immunodeficiency Virus Infection Compared with the General Population
Savès, M., Chêne, G., Ducimetière, P., Leport, C., Moal, G. L., Amouyel, P., Arveiler, D., Ruidavets, J., Reynes, J., Bingham, A., et al. (2003) · Clinical Infectious Diseases · doi:10.1086/375844 · Cited by 399
Cigarette Smoking and the Desire to Quit Among Individuals Living with HIV
Mamary, E. M., Bahrs, D., & Martinez, S. A. (2002) · AIDS Patient Care and STDs · doi:10.1089/108729102753429389 · Cited by 155
Long term probability of detection of HIV-1 drug resistance after starting antiretroviral therapy in routine clinical practice
UK CHIC Study Group The UK Collaborative Group on HIV Drug Resistance (2005) · AIDS · doi:10.1097/01.aids.0000162337.58557.3d · Cited by 149
Estimating the proportion of patients infected with HIV who will die of comorbid diseases
Braithwaite, R. S., Justice, A. C., Chang, C. H., Fusco, J. S., Raffanti, S. R., Wong, J. B., & Roberts, M. S. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2004.12.034 · Cited by 136
A Clinically Prognostic Scoring System for Patients Receiving Highly Active Antiretroviral Therapy: Results from the EuroSIDA Study
Lundgren, J. D., Mocroft, A., Gatell, J. M., Ledergerber, B., Monforte, A. D., Hermans, P., Goebel, F., Blaxhult, A., Kirk, O., Phillips, A. N., et al. (2002) · The Journal of Infectious Diseases · doi:10.1086/338267 · Cited by 129
Virologic and Immunologic Response, Clinical Progression, and Highly Active Antiretroviral Therapy Adherence
Press, N., TYNDALL, M. W., Wood, E., Hogg, R. S., & Montaner, J. S. G. (2002) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/00126334-200212153-00005 · Cited by 116

Show all 21 references

Research works printed but not linked: 1

Christensen PB, 1998, Ugeskr Laeger, 160, 3529

Sorted by citations

Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & Initiative, F. T. S. (2007) · PLoS Medicine · doi:10.1371/journal.pmed.0040297 · Cited by 8,613
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
Vandenbroucke, J. P., Elm, E. V., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., Egger, M., & initiative, F. T. S. (2007) · Annals of Internal Medicine · doi:10.7326/0003-4819-147-8-200710160-00010-w1 · Cited by 3,543
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and elaboration
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2014) · International Journal of Surgery · doi:10.1016/j.ijsu.2014.07.014 · Cited by 2,969
Strengthening the Reporting of Observational Studies in Epidemiology (STROBE): Explanation and Elaboration
Vandenbroucke, J. P., von Elm, E., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S. J., Poole, C., Schlesselman, J. J., & Egger, M. (2007) · Epidemiology · doi:10.1097/ede.0b013e3181577511 · Cited by 2,779
Antiretroviral Treatment of Adult HIV Infection
Thompson, M., Aberg, J. A., Hoy, J., Telenti, A., Benson, C., Cahn, P. E., Eron, J. J., Günthard, H. F., Hammer, S. M., Reiss, P., et al. (2012) · JAMA · doi:10.1001/jama.2012.7961 · Cited by 2,493
Life expectancy of individuals on combination antiretroviral therapy in high-income countries: a collaborative analysis of 14 cohort studies.
(2008) · The Lancet · doi:10.1016/s0140-6736(08)61113-7 · Cited by 1,661
HIV Infection, Inflammation, Immunosenescence, and Aging
Deeks, S. G. (2011) · Annual Review of Medicine · doi:10.1146/annurev-med-042909-093756 · Cited by 1,349
Incidence of Types of Cancer among HIV-Infected Persons Compared with the General Population in the United States, 1992–2003
Patel, P., Hanson, D. L., Sullivan, P. S., Novak, R. M., Moorman, A. C., Tong, T. C., Holmberg, S. D., Brooks, J. T., & for the Adult and Adolescent Spectrum of Disease Project and HIV Outpatient Study Investigators* (2008) · Annals of Internal Medicine · doi:10.7326/0003-4819-148-10-200805200-00005 · Cited by 946
Cross-sectional Comparison of the Prevalence of Age-Associated Comorbidities and Their Risk Factors Between HIV-Infected and Uninfected Individuals: The AGEhIV Cohort Study
Schouten, J., Wit, F. W. N. M., Stolte, I. G., Kootstra, N. A., van der Valk, M., Geerlings, S. E., Prins, M., Reiss, P., for the AGEhIV Cohort Study Group, Reiss, P., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu701 · Cited by 773
HIV infection, antiretroviral treatment, ageing, and non-AIDS related morbidity.
Deeks, S. G., & Phillips, A. N. (2009) · BMJ · doi:10.1136/bmj.a3172 · Cited by 704
Comparison of Overall and Comorbidity-Free Life Expectancy Between Insured Adults With and Without HIV Infection, 2000-2016
Marcus, J. L., Leyden, W. A., Alexeeff, S., Anderson, A. N., Hechter, R. C., Hu, H., Lam, J. O., Towner, W. J., Yuan, Q. H., Horberg, M. A., et al. (2020) · JAMA Network Open · doi:10.1001/jamanetworkopen.2020.7954 · Cited by 667
HIV-Infected Individuals with Low CD4/CD8 Ratio despite Effective Antiretroviral Therapy Exhibit Altered T Cell Subsets, Heightened CD8+ T Cell Activation, and Increased Risk of Non-AIDS Morbidity and Mortality
Serrano-Villar, S., Sainz, T., Lee, S. A., Hunt, P. W., Sinclair, E., Shacklett, B. L., Ferre, A. L., Hayes, T. L., Somsouk, M., Hsue, P. Y., et al. (2014) · PLoS Pathogens · doi:10.1371/journal.ppat.1004078 · Cited by 611
HIV and Aging: State of Knowledge and Areas of Critical Need for Research. A Report to the NIH Office of AIDS Research by the HIV and Aging Working Group
High, K. P., Brennan-Ing, M., Clifford, D. B., Cohen, M. H., Currier, J., Deeks, S. G., Deren, S., Effros, R. B., Gebo, K., Goronzy, J. J., et al. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e31825a3668 · Cited by 522
Changes in the Risk of Death After HIV Seroconversion Compared With Mortality in the General Population
Bhaskaran, K. (2008) · JAMA · doi:10.1001/jama.300.1.51 · Cited by 495
Gut Epithelial Barrier Dysfunction and Innate Immune Activation Predict Mortality in Treated HIV Infection
Hunt, P. W., Sinclair, E., Rodriguez, B. A., Shive, C. L., Clagett, B. M., Funderburg, N., Robinson, J., Huang, Y., Epling, L., Martin, J. N., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu238 · Cited by 481
The effect of combined antiretroviral therapy on the overall mortality of HIV-infected individuals
The HIV-CAUSAL Collaboration (2009) · AIDS · doi:10.1097/qad.0b013e3283324283 · Cited by 466
Antiretroviral therapy and management of HIV infection
Volberding, P. A., & Deeks, S. G. (2010) · The Lancet · doi:10.1016/s0140-6736(10)60676-9 · Cited by 461
Projected life expectancy of people with HIV according to timing of diagnosis
Nakagawa, F., Lodwick, R. K., Smith, C. J., Smith, R. D., Cambiano, V., Lundgren, J. D., Delpech, V., & Phillips, A. N. (2011) · AIDS · doi:10.1097/qad.0b013e32834dcec9 · Cited by 444
Narrowing the gap in life expectancy between HIV-infected and HIV-uninfected individuals with access to care.
Marcus, J. L., Chao, C. R., Leyden, W. A., Xu, L., Quesenberry, C. P., Klein, D. B., Towner, W. J., Horberg, M. A., & Silverberg, M. J. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000001014 · Cited by 439
Life Expectancies of South African Adults Starting Antiretroviral Treatment: Collaborative Analysis of Cohort Studies
Johnson, L. F., Mossong, J., Dorrington, R., Schomaker, M., Hoffmann, C. J., Keiser, O., Fox, M. P., Wood, R., Prozesky, H. W., Giddy, J., et al. (2013) · PLoS Medicine · doi:10.1371/journal.pmed.1001418 · Cited by 437
Life expectancy of HIV ‐positive people after starting combination antiretroviral therapy: a meta‐analysis
Teeraananchai, S., Kerr, S. J., Amin, J., Ruxrungtham, K., & Law, M. G. (2016) · HIV Medicine · doi:10.1111/hiv.12421 · Cited by 435
Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals
van Sighem, A., Gras, L. A., Reiss, P., Brinkman, K., & de Wolf, F. (2010) · AIDS · doi:10.1097/qad.0b013e32833a3946 · Cited by 397
Life expectancy living with HIV
Nakagawa, F., May, M., & Phillips, A. N. (2012) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0b013e32835ba6b1 · Cited by 374
Impact of late diagnosis and treatment on life expectancy in people with HIV-1: UK Collaborative HIV Cohort (UK CHIC) Study
May, M., Gompels, M., Delpech, V., Porter, K., Post, F., Johnson, M., Dunn, D., Palfreeman, A., Gilson, R., Gazzard, B., et al. (2011) · BMJ · doi:10.1136/bmj.d6016 · Cited by 363
Residual Immune Dysregulation Syndrome in Treated HIV infection
Lederman, M. M., Funderburg, N., Sékaly, R., Klatt, N. R., & Hunt, P. W. (2013) · Advances in immunology · doi:10.1016/b978-0-12-407707-2.00002-3 · Cited by 348
Valganciclovir Reduces T Cell Activation in HIV-Infected Individuals With Incomplete CD4+ T Cell Recovery on Antiretroviral Therapy
Hunt, P. W., Martin, J. N., Sinclair, E., Epling, L., Teague, J., Jacobson, M. Z., Tracy, R. P., Corey, L., & Deeks, S. G. (2011) · The Journal of Infectious Diseases · doi:10.1093/infdis/jir060 · Cited by 344
Increased prevalence of subclinical coronary atherosclerosis detected by coronary computed tomography angiography in HIV-infected men
Lo, J., Abbara, S., Shturman, L. D., Soni, A. V., Wei, J., Rocha-Filho, J. A., Nasir, K., & Grinspoon, S. K. (2009) · AIDS · doi:10.1097/qad.0b013e328333ea9e · Cited by 330
HIV and aging: time for a new paradigm.
Justice, A. C. (2010) · Current HIV/AIDS Reports · doi:10.1007/s11904-010-0041-9 · Cited by 309
Common elements in self-management of HIV and other chronic illnesses: an integrative framework
Swendeman, D., Ingram, B. L., & Rotheram-Borus, M. J. (2009) · AIDS Care · doi:10.1080/09540120902803158 · Cited by 281
“In Denmark, estimated median survival for young PLH is 35 years (Lohse et al., 2007).”
Background
HIV and aging
Wing, E. J. (2016) · International Journal of Infectious Diseases · doi:10.1016/j.ijid.2016.10.004 · Cited by 304
. Inflammation and mortality in HIV-infected adults: analysis of the FRAM study cohort.
Tien, P. C., Choi, A. I., Zolopa, A. R., Benson, C., Tracy, R., Scherzer, R., Bacchetti, P., Shlipak, M., & Grunfeld, C. (2010) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181e66216 · Cited by 279
Smoking and life expectancy among HIV-infected individuals on antiretroviral therapy in Europe and North America
Helleberg, M., May, M. T., Ingle, S. M., Dabis, F., Reiss, P., Fätkenheuer, G., Costagliola, D., d’Arminio, A., Cavassini, M., Smith, C., et al. (2015) · AIDS · doi:10.1097/qad.0000000000000540 · Cited by 268
Self-citation
Life expectancy in HIV-positive persons in Switzerland
Gueler, A., Moser, A., Calmy, A., Günthard, H. F., Bernasconi, E., Furrer, H., Fux, C. A., Battegay, M., Cavassini, M. L., Vernazza, P., et al. (2016) · AIDS · doi:10.1097/qad.0000000000001335 · Cited by 260
Pharmacological Treatment of Painful HIV-Associated Sensory Neuropathy: A Systematic Review and Meta-Analysis of Randomised Controlled Trials
Phillips, T., Cherry, C. L., Cox, S., Marshall, S. J., & Rice, A. S. C. (2010) · PLoS ONE · doi:10.1371/journal.pone.0014433 · Cited by 257
All-cause mortality in treated HIV-infected adults with CD4 >=500/mm3 compared with the general population: evidence from a large European observational cohort collaboration
Lewden, C., Bouteloup, V., Wit, S. D., Sabin, C. A., Mocroft, A., Wasmuth, J. ‐., van Sighem, A., Kirk, O., Obel, N., Panos, G., et al. (2011) · International Journal of Epidemiology · doi:10.1093/ije/dyr164 · Cited by 255
Self-citation
Incidence, Clinical Presentation, and Outcome of Progressive Multifocal Leukoencephalopathy in HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era: A Nationwide Cohort Study
Engsig, F. N., Hansen, A. E., Omland, L. H., Kronborg, G., Gerstoft, J., Laursen, A. L., Pedersen, C., Mogensen, C. B., Nielsen, L. N., & Obel, N. (2008) · The Journal of Infectious Diseases · doi:10.1086/595299 · Cited by 239
Self-citation
Effects of statin therapy on coronary artery plaque volume and high-risk plaque morphology in HIV-infected patients with subclinical atherosclerosis: a randomised, double-blind, placebo-controlled trial
Lo, J., Lu, M. T., Ihenachor, E. J., Wei, J., Looby, S. E. D., Fitch, K. V., Oh, J.-H., Zimmerman, C. O., Hwang, J. J., Abbara, S., et al. (2015) · The Lancet HIV · doi:10.1016/s2352-3018(14)00032-0 · Cited by 236
Life Expectancy After HIV Diagnosis Based on National HIV Surveillance Data From 25 States, United States
Harrison, K. M., Song, R., & Zhang, X. (2009) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e3181b563e7 · Cited by 233
State of the Science Conference
Grinspoon, S. K., Grünfeld, C., Kotler, D. P., Currier, J. S., Lundgren, J. D., Dubé, M. P., Lipshultz, S. E., Hsue, P. Y., Squires, K., Schambelan, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.189622 · Cited by 230
The Next Therapeutic Challenge in HIV: Polypharmacy
Edelman, E. J., Gordon, K. S., Glover, J. G., McNicholl, I. R., Fiellin, D. A., & Justice, A. C. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0093-9 · Cited by 232
HIV-1-Related Central Nervous System Disease: Current Issues in Pathogenesis, Diagnosis, and TreatmentPreprint
Spudich, S., & González‐Scarano, F. (2012) · Cold Spring Harbor Perspectives in Medicine · doi:10.1101/cshperspect.a007120 · Cited by 222
Understanding HIV Latency: The Road to an HIV Cure
Dahabieh, M. S., Battivelli, E., & Verdin, E. M. (2015) · Annual Review of Medicine · doi:10.1146/annurev-med-092112-152941 · Cited by 215
Increased Risk of Serious Non-AIDS-Related Events in HIV-Infected Subjects on Antiretroviral Therapy Associated with a Low CD4/CD8 Ratio
Villar, S. S., Pérez-Elı́as, M. J., Dronda, F., Casado, J. L., Moreno, A. M., Royuela, A., Pérez-Molina, J. A., Sainz, T., Navas, E., Hermida, J. M., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0085798 · Cited by 210
Gut epithelial barrier and systemic inflammation during chronic HIV infection
Somsouk, M., Estes, J. D., Deléage, C., Dunham, R. M., Albright, R. G., Inadomi, J. M., Martin, J. N., Deeks, S. G., McCune, J. M., & Hunt, P. W. (2014) · AIDS · doi:10.1097/qad.0000000000000511 · Cited by 203
Association of HIV and ART with cardiometabolic traits in sub-Saharan Africa: a systematic review and meta-analysis
Dillon, D., Gurdasani, D., Riha, J., Ekoru, K., Asiki, G., Mayanja, B. N., Levitt, N. S., Crowther, N. J., Nyirenda, M., Njelekela, M. A., et al. (2013) · International Journal of Epidemiology · doi:10.1093/ije/dyt198 · Cited by 201
Mejorar la comunicación de estudios observacionales en epidemiología (STROBE): explicación y elaboración
Vandenbroucke, J. P., von Elm, E. B., Altman, D. G., Gøtzsche, P. C., Mulrow, C. D., Pocock, S., Poole, C., Schlesselman, J. J., & Egger, M. (2009) · Gaceta Sanitaria · doi:10.1016/j.gaceta.2008.12.001 · Cited by 215
Cytomegalovirus Coinfection Is Associated With an Increased Risk of Severe Non–AIDS-Defining Events in a Large Cohort of HIV-Infected Patients
Lichtner, M., Cicconi, P., Vita, S., Cozzi‐Lepri, A., Galli, M., Caputo, S. L., Saracino, A., Luca, A. D., Moioli, M. C., Maggiolo, F., et al. (2014) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiu417 · Cited by 194
Do people with HIV infection have a normal life expectancy in the era of combination antiretroviral therapy?
Sabin, C. A. (2013) · BMC Medicine · doi:10.1186/1741-7015-11-251 · Cited by 181
Combined effect of Vacc-4x, recombinant human granulocyte macrophage colony-stimulating factor vaccination, and romidepsin on the HIV-1 reservoir (REDUC): a single-arm, phase 1B/2A trial
Leth, S., Schleimann, M. H., Nissen, S. K., Højen, J. F., Olesen, R., Graversen, M. E., Jørgensen, S., Kjær, A. S., Denton, P. W., Mørk, A., et al. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)30055-8 · Cited by 178
Long-term Mortality in HIV-Positive Individuals Virally Suppressed for >3 Years With Incomplete CD4 Recovery
Engsig, F. N., Κατσαρού, Ό., Katsarou, O., Dabis, F., Reiss, P., Gill, J., Porter, K., Sabin, C. A., Riordan, A. I., Fätkenheuer, G., et al. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu038 · Cited by 176
Self-citation
HIV and HAART-Associated Dyslipidemia
Feeney, E. R., & Mallon, P. W. G. (2011) · The Open Cardiovascular Medicine Journal · doi:10.2174/1874192401105010049 · Cited by 173
HIV and the Gut Microbiota: Composition, Consequences, and Avenues for Amelioration
Vujkovic-Cvijin, I., & Somsouk, M. (2019) · Current HIV/AIDS Reports · doi:10.1007/s11904-019-00441-w · Cited by 180
The cost-effectiveness of harm reduction
Wilson, D. P., Donald, B., Shattock, A. J., Wilson, D. P., & Fraser‐Hurt, N. (2014) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2014.11.007 · Cited by 172
T-cell aging in rheumatoid arthritis
Weyand, C. M., Yang, Z., & Goronzy, J. J. (2014) · Current Opinion in Rheumatology · doi:10.1097/bor.0000000000000011 · Cited by 164
Antiretroviral medication adherence and the development of class-specific antiretroviral resistance
Gardner, E. M., Burman, W. J., Steiner, J. F., Anderson, P. L., & Bangsberg, D. R. (2009) · AIDS · doi:10.1097/qad.0b013e32832ba8ec · Cited by 163
. Towards a combined prognostic index for survival in HIV infection: the role of non-HIV biomarkers.
Justice, A., McGinnis, K., Skanderson, M., Chang, C., Gibert, C., Goetz, M., Rimland, D., Rodriguez‐Barradas, M., Oursler, K., Brown, S., et al. (2010) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00757.x · Cited by 159
The CD4/CD8 ratio in HIV-infected subjects is independently associated with T-cell activation despite long-term viral suppression
Villar, S. S., Gutiérrez, C., Vallejo, A., Hernández‐Novoa, B., Díaz, L., Abad-Fernández, M., Madrid, N., Dronda, F., Zamora, J., Muñoz‐Fernández, M. Á., et al. (2012) · Journal of Infection · doi:10.1016/j.jinf.2012.09.013 · Cited by 159
Cardiovascular risks associated with abacavir and tenofovir exposure in HIV-infected persons
Choi, A. I., Vittinghoff, E., Deeks, S. G., Weekley, C. C., Li, Y., & Shlipak, M. G. (2011) · AIDS · doi:10.1097/qad.0b013e328347fa16 · Cited by 156
Frailty, HIV Infection, and Mortality in an Aging Cohort of Injection Drug Users
Piggott, D. A., Muzaale, A. D., Mehta, S. H., Brown, T. T., Patel, K. V., Leng, S. X., & Kirk, G. D. (2013) · PLoS ONE · doi:10.1371/journal.pone.0054910 · Cited by 153
The CD 4: CD 8 ratio is associated with markers of age‐associated disease in virally suppressed HIV ‐infected patients with immunological recovery
Villar, S. S., Moreno, S., Fuentes, M. E., Sánchez, C., Ávila, M., Sainz, T., de Villar, N., Fernández‐Cruz, A., & Estrada, V. (2013) · HIV Medicine · doi:10.1111/hiv.12081 · Cited by 155
Impact of Non-HIV and HIV Risk Factors on Survival in HIV-Infected Patients on HAART: A Population-Based Nationwide Cohort Study
Obel, N., Omland, L. H., Kronborg, G., Larsen, C. S., Pedersen, C., Pedersen, G., Sørensen, H. T., & Gerstoft, J. (2011) · PLoS ONE · doi:10.1371/journal.pone.0022698 · Cited by 145
Self-citation
The cost-effectiveness of Vancouver's supervised injection facility
Bayoumi, A. M., & Zaric, G. S. (2008) · Canadian Medical Association Journal · doi:10.1503/cmaj.080808 · Cited by 144
Abacavir and risk of myocardial infarction in HIV‐infected patients on highly active antiretroviral therapy: a population‐based nationwide cohort study
Obel, N., Farkas, D. K., Kronborg, G., Larsen, C. S., Pedersen, G., Riis, A. H., Pedersen, C. D., Gerstoft, J., & Sørensen, H. T. (2009) · HIV Medicine · doi:10.1111/j.1468-1293.2009.00751.x · Cited by 143
Self-citation
Risk of Diabetes Mellitus in Persons with and without HIV: A Danish Nationwide Population-Based Cohort Study
Rasmussen, L. D., Mathiesen, E. R., Kronborg, G., Pedersen, C., Gerstoft, J., & Obel, N. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044575 · Cited by 140
Self-citation
Premature and accelerated aging: HIV or HAART?
Smith, R. L., de Boer, R., Brul, S., Budovskaya, Y. V., & van der Spek, H. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2012.00328 · Cited by 138
The immunologic effects of maraviroc intensification in treated HIV-infected individuals with incomplete CD4+ T-cell recovery: a randomized trial
Hunt, P. W., Shulman, N. S., Hayes, T. L., Dahl, V., Somsouk, M., Funderburg, N., McLaughlin, B. E., LANDAY, A. L., Adeyemi, O. M., Gilman, L. T., et al. (2013) · Blood · doi:10.1182/blood-2012-06-436345 · Cited by 138
What Is Killing People with Hepatitis C Virus Infection?
Grebely, J., & Dore, G. J. (2011) · Seminars in Liver Disease · doi:10.1055/s-0031-1297922 · Cited by 136
Effects of a multicomponent intervention to streamline initiation of antiretroviral therapy in Africa: a stepped-wedge cluster-randomised trial
Amanyire, G., Semitala, F. C., Namusobya, J., Katuramu, R., Kampiire, L., Wallenta, J., Charlebois, E., Camlin, C., Kahn, J., Chang, W., et al. (2016) · The Lancet HIV · doi:10.1016/s2352-3018(16)30090-x · Cited by 141
Hepatitis B and long-term HIV outcomes in coinfected HAART recipients
Hoffmann, C. J., Seaberg, E. C., Young, S. A., Witt, M. D., DʼAcunto, K., Phair, J., & Thio, C. L. (2009) · AIDS · doi:10.1097/qad.0b013e32832e463a · Cited by 132
High HIV incidence in a community with high HIV prevalence in rural South Africa: findings from a prospective population-based study
Bärnighausen, T., Tanser, F. C., Gqwede, Z., Mbizana, C., Herbst, K., & Newell, M. (2008) · AIDS · doi:10.1097/qad.0b013e3282f2ef43 · Cited by 131
HIV cure and eradication: how will we get from the laboratory to effective clinical trials?
Lewin, S. R., & Rouzioux, C. (2011) · AIDS · doi:10.1097/qad.0b013e3283467041 · Cited by 133
HIV type 1 infection, and not short-term HAART, induces endothelial dysfunction
Francisci, D., Giannini, S., Baldelli, F., Leone, M., Belfiori, B., Guglielmini, G., Malincarne, L., & Gresele, P. (2009) · AIDS · doi:10.1097/qad.0b013e328325a87c · Cited by 129
Cigarette Smoking among HIV+ Men and Women: Examining Health, Substance Use, and Psychosocial Correlates across the Smoking Spectrum
Webb, M. S., Vanable, P. A., Carey, M. P., & Blair, D. C. (2007) · Journal of Behavioral Medicine · doi:10.1007/s10865-007-9112-9 · Cited by 129
Cell-associated HIV RNA: a dynamic biomarker of viral persistence
Pasternak, A. O., Lukashov, V. V., & Berkhout, B. (2013) · Retrovirology · doi:10.1186/1742-4690-10-41 · Cited by 138
Virologically Suppressed HIV Patients Show Activation of NK Cells and Persistent Innate Immune Activation
Lichtfuss, G. F., Cheng, W., Farsakoglu, Y., Paukovics, G., Rajasuriar, R., Velayudham, P., Kramski, M., Hearps, A. C., Cameron, P. U., Lewin, S. R., et al. (2012) · The Journal of Immunology · doi:10.4049/jimmunol.1200458 · Cited by 127
Efavirenz: a decade of clinical experience in the treatment of HIV
Maggiolo, F. (2009) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkp334 · Cited by 126
Vitamin D and Calcium Attenuate Bone Loss With Antiretroviral Therapy Initiation
Overton, E. T., Chan, E. S., Brown, T. T., Tebas, P., McComsey, G. A., Melbourne, K. M., Napoli, A., Hardin, W. R., Ribaudo, H. J., & Yin, M. T. (2015) · Annals of Internal Medicine · doi:10.7326/m14-1409 · Cited by 122
Long-Term Mortality in HIV-Infected Individuals 50 Years or Older: A Nationwide, Population-Based Cohort Study
Legarth, R. A., Ahlström, M. G., Kronborg, G., Larsen, C. S., Pedersen, C., Pedersen, G., Mohey, R., Gerstoft, J., & Obel, N. (2016) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0000000000000825 · Cited by 121
Self-citation
Complementary and alternative medicine use among HIV-positive people: research synthesis and implications for HIV care
Littlewood, R. A., & Vanable, P. A. (2008) · AIDS Care · doi:10.1080/09540120701767216 · Cited by 120
Recomendaciones de Gesida/Plan Nacional sobre el Sida respecto al tratamiento antirretroviral en adultos infectados por el virus de la inmunodeficiencia humana (actualización febrero de 2009)
de Gesida, P. D. E., & el Sida, P. N. S. (2009) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2008.11.002 · Cited by 121
Is the central nervous system a reservoir of HIV-1?
Gray, L. R., Roche, M., Flynn, J. K., Wesselingh, S. L., Gorry, P. R., & Churchill, M. J. (2014) · Current Opinion in HIV and AIDS · doi:10.1097/coh.0000000000000108 · Cited by 116
High Rates of Retention and Viral Suppression in the US HIV Safety Net System: HIV Care Continuum in the Ryan White HIV/AIDS Program, 2011
Doshi, R. K., MILBERG, J. A., Isenberg, D., Matthews, T., Malitz, F. E., Matosky, M., Trent-Adams, S., Hopson, D. P., & Cheever, L. W. (2014) · Clinical Infectious Diseases · doi:10.1093/cid/ciu722 · Cited by 118
Cohort Profile: The Danish HIV Cohort Study
Obel, N., Engsig, F. N., Rasmussen, L. D., Larsen, M. V., Omland, L. H., & Sørensen, H. T. (2008) · International Journal of Epidemiology · doi:10.1093/ije/dyn192 · Cited by 116
Self-citation
Review: The Need for Smoking Cessation Among HIV-Positive Smokers
Nahvi, S., & Cooperman, N. A. (2009) · AIDS Education and Prevention · doi:10.1521/aeap.2009.21.3_supp.14 · Cited by 115
Changes in mortality rates and causes of death in a population-based cohort of persons living with and without HIV from 1996 to 2012
study, F. T. C. O. A. S. U. T. (., Eyawo, O., Franco‐Villalobos, C., Hull, M., Nohpal, A., Samji, H., Sereda, P., Lima, V. D., Shoveller, J., Moore, D. M., et al. (2017) · BMC Infectious Diseases · doi:10.1186/s12879-017-2254-7 · Cited by 114
Cardiac manifestations of HIV infection: an African perspective
Ntsekhe, M., & Mayosi, B. M. (2008) · Nature Clinical Practice Cardiovascular Medicine · doi:10.1038/ncpcardio1437 · Cited by 111
Improved survival in HIV-infected persons: consequences and perspectives
Lohse, N., Hansen, A. E., Gerstoft, J., & Obel, N. (2007) · Journal of Antimicrobial Chemotherapy · doi:10.1093/jac/dkm241 · Cited by 111
Self-citation
Cystatin C, Albuminuria, and 5-Year All-Cause Mortality in HIV-Infected Persons
Choi, A. I., Scherzer, R., Bacchetti, P., Tien, P. C., Saag, M. S., Gibert, C. L., Szczech, L. A. M., Grünfeld, C., & Shlipak, M. G. (2010) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2010.05.019 · Cited by 110
Frailty in HIV-Infected Adults in South Africa
Pathai, S., Gilbert, C. E., Weiss, H. A., Cook, C., Wood, R., Bekker, L., & Lawn, S. D. (2012) · JAIDS Journal of Acquired Immune Deficiency Syndromes · doi:10.1097/qai.0b013e318273b631 · Cited by 110
Review: Thromboses among HIV-Infected Patients during the Highly Active Antiretroviral Therapy Era
Crum‐Cianflone, N. F., Weekes, J., & Bavaro, M. F. (2008) · AIDS Patient Care and STDs · doi:10.1089/apc.2008.0010 · Cited by 110
Understanding High Fertility Desires and Intentions Among a Sample of Urban Women Living with HIV in the United States
Finocchario‐Kessler, S., Sweat, M. D., Dariotis, J. K., Trent, M., Kerrigan, D. L., Keller, J. M., & Anderson, J. (2009) · AIDS and Behavior · doi:10.1007/s10461-009-9637-8 · Cited by 109
The Presentation, Diagnosis, and Treatment of Sexually Transmitted Infections
Wagenlehner, F. R. A., Brockmeyer, N. H., Discher, T., Friese, K., & Wichelhaus, T. A. (2016) · Deutsches Ärzteblatt international · doi:10.3238/arztebl.2016.0011 · Cited by 109
Life expectancy of HIV-positive adults: a review
May, M., & Ingle, S. M. (2011) · Sexual Health · doi:10.1071/sh11046 · Cited by 108
Aortic Stiffness in Untreated Adult Patients With Human Immunodeficiency Virus Infection
Schillaci, G., Socio, G. V. D., Pucci, G., Mannarino, M. R., Helou, J., Pirro, M., & Mannarino, E. (2008) · Hypertension · doi:10.1161/hypertensionaha.108.114660 · Cited by 108
HIV-1 infection induces strong production of IP-10 through TLR7/9-dependent pathways
Simmons, R. P., Scully, E. P., Groden, E. E., Arnold, K. B., Chang, J. J., Lane, K., Lifson, J. D., Rosenberg, E. S., Lauffenburger, D. A., & Altfeld, M. A. (2013) · AIDS · doi:10.1097/01.aids.0000432455.06476.bc · Cited by 106
HIV Infection and Compromised Mucosal Immunity: Oral Manifestations and Systemic Inflammation
Heron, S., & Elahi, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00241 · Cited by 104
Impact of Hepatitis C Virus Coinfection on Response to Highly Active Antiretroviral Therapy and Outcome in HIV-Infected Individuals: A Nationwide Cohort Study
Weis, N. M., Lindhardt, B. Ø., Kronborg, G., Hansen, A. E., Laursen, A. L., Christensen, P. B., Nielsen, H. I., Møller, A., Sørensen, H. T., & Obel, N. (2006) · Clinical Infectious Diseases · doi:10.1086/503569 · Cited by 104
Self-citation
HIV-associated changes in the enteric microbial community: potential role in loss of homeostasis and development of systemic inflammation
Gootenberg, D. B., Paer, J. M., Luévano, J. M., & Kwon, D. S. (2016) · Current Opinion in Infectious Diseases · doi:10.1097/qco.0000000000000341 · Cited by 103
Sampling strategies for selecting general population comparison cohorts
Heide‐Jørgensen, U., Adelborg, K., Kahlert, J. A., Sørensen, H. T., & Pedersen, L. H. (2018) · Clinical Epidemiology · doi:10.2147/clep.s164456 · Cited by 102
Self-citation
Copy-Years Viremia as a Measure of Cumulative Human Immunodeficiency Virus Viral Burden
Cole, S. R., Napravnik, S., Mugavero, M. J., Lau, B., Eron, J., & Saag, M. S. (2009) · American Journal of Epidemiology · doi:10.1093/aje/kwp347 · Cited by 102

Authors: Lohse, N., Hansen, A.-B. E., Pedersen, G., Kronborg, G., Gerstoft, J., Sørensen, H. T., Væth, M., & Obel, N.
Affiliations: Boston University (US)
ORCID: Lohse, Nicolai
Hansen, Ann-Brit Eg
Pedersen, Gitte
Kronborg, Gitte
Gerstoft, Jan
Sørensen, Henrik Toft
Væth, Michael
Obel, Niels
Venue: Annals of Internal Medicine
Publisher: American College of Physicians
Published: 2007-01-16
Volume: 146
Issue: 2
Pages: 87-95
ISSN: 0003-4819 (ISSN-L)
1539-3704
DOI: 10.7326/0003-4819-146-2-200701160-00003
OpenAlex: W1967548282
Cited by: 748
References: 21
Citations by year: 2026: 3 · 2025: 8 · 2024: 15 · 2023: 9 · 2022: 14 · 2021: 17 · 2020: 19 · 2019: 15 · 2018: 34 · 2017: 32 · 2016: 44 · 2015: 54 · 2014: 62 · 2013: 75 · 2012: 73
FWCI: 39.70
Type: journal article
Language: en
Open access: closed
Licence: www.acpjournals.org/journal/aim/text-and-data-mining (tdm)
Locations: Annals of Internal Medicine (publishedVersion)
PubMed (publishedVersion)
Research at the University of Copenhagen (University of Copenhagen) (submittedVersion)
University of Southern Denmark Research Portal (University of Southern Denmark) (submittedVersion)
Topics: Health Sciences › Medicine › Infectious Diseases › HIV/AIDS Research and Interventions
Health Sciences › Medicine › Infectious Diseases › HIV-related health complications and treatments
Health Sciences › Medicine › Epidemiology › HIV, Drug Use, Sexual Risk
Keywords: HIV infection, survival, mortality, age-specific mortality, excess mortality, hepatitis C coinfection, highly active antiretroviral therapy, HIV cohort, Denmark, life tables, HIV treatment outcomes
MeSH terms: Adult, Cause of Death, Denmark, Female, Hepatitis C, Humans, Life Expectancy, Male, Middle Aged, Prospective Studies, HIV Infections, Survival Rate, Case-Control Studies, Antiretroviral Therapy, Highly Active

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

. Survival of persons with and without HIV infection in Denmark, 1995-2005.

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Citations

Cites

Cited by

Related

Metadata

Record

About these checks